Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Rongfang Shan"'
Autor:
Xiaoli Li, Anshun He, Bingyan Liu, Rongfang Shan, Juan Zhu, Xiaoyue Li, Tian Xie, Yue Li, Mengmeng Chen, He Su, Chaoyang Zhang, Lufeng Li, Dongmei Cheng, Juan Chen, Ying Wang, Yue Su, Yuanyuan Xu, Zhuoran Li, Huan Zhou, Wei Chen, Yuanyuan Liu
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundTo assess the bioequivalence between Gan & Lee (GL) glargine U300 and Toujeo® regarding pharmacokinetics (PK), pharmacodynamics (PD), and safety in Chinese healthy male participants.MethodsA single-center, randomized, double-blind, single-
Externí odkaz:
https://doaj.org/article/6b212e5d6d6f4bc68bcfc65d24035caf
Autor:
Ying Wang, Bangzhong Tang, Jing Xie, Xiaoqin Wang, Peng Ren, Guangmei Wu, Cuixia He, Minhui Zhu, Yue Su, Jiaxiang Ding, Yuanyuan Xu, Ling Fan, Qin Ge, Yuzhou Ding, Juan Zhu, Bingyan Liu, Rongfang Shan, Huan Zhou
Publikováno v:
BMC Pharmacology and Toxicology, Vol 24, Iss 1, Pp 1-9 (2023)
Abstract Purpose The study was aimed at evaluating the bioequivalence and safety of oseltamivir phosphate for suspension, provided by Shenzhen Beimei Pharmaceutical Co. Ltd. and manufactured by Hetero Labs Limited, and the reference product TAMIFLU®
Externí odkaz:
https://doaj.org/article/d7f09b03e00c4c0585276ec1370484e6
Autor:
Huan Zhou, Xingyu Zhu, Yan Yao, Yue Su, Jing Xie, Minhui Zhu, Cuixia He, Jiaxiang Ding, Yuanyuan Xu, Rongfang Shan, Ying Wang, Xiangdi Zhao, Yuzhou Ding, Bingyan Liu, Zhonghuan Shao, Yuanyuan Liu, Tao Xu, Yunqiu Xie
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Objective: To clarify the molecular mechanism of TMEM88 regulating lipid synthesis and metabolism cytokine in NAFLD.Methods:In vivo, NAFLD model mice were fed by a Methionine and Choline-Deficient (MCD) diet. H&E staining and immunohistochemistry exp
Externí odkaz:
https://doaj.org/article/f00f984f7aaa497c902d3a821acd9e26
Autor:
Fei Guo, Bingyan Liu, Xiaoli Li, Haidong Wang, Xingyu Zhu, Yue Su, Cuixia He, Minhui Zhu, Jiaxiang Ding, Yuanyuan Xu, Xiangdi Zhao, Ying Wang, Rongfang Shan, Juan Zhu, Jing Xie, Qin Ge, Ling Fan, Yuzhou Ding, Yunqiu Xie, Chaoyang Zhang, Hongtao Li, Hongju Wang, Huan Zhou
Publikováno v:
Cancer Chemotherapy and Pharmacology. 91:143-156
Autor:
Hongtao Li, Xiangdi Zhao, Jing Xie, Xingyu Zhu, Yue Su, Cuixia He, Jiaxiang Ding, Minhui Zhu, Yuanyuan Xu, Ying Wang, Rongfang Shan, Bingyan Liu, Yuzhou Ding, Yuanyuan Liu, Huan Zhou, Yunqiu Xie
Publikováno v:
BMC Pharmacology and Toxicology. 24
Background The biosimilar landscape for malignancies continues to grow, with several biosimilars for reference product bevacizumab currently available. Bevacizumab has been shown to be well tolerated; however, the safety of recombinant humanized anti
Autor:
Xiaoli Li, Yuyan Liu, Minhui Zhu, Cuixia He, Yuanyuan Xu, Jiaxiang Ding, Ying Wang, Rongfang Shan, Bingyan Liu, Yuzhou Ding, Jing Xie, Huan Zhou, Zhiqiang Wang, Yuanyuan Liu
Publikováno v:
Investigational New Drugs.
Autor:
Pingyu Yang, Rongfang Shan, Yinli Wei, Juan Ni, Haoyang Chen, Chengying Yang, Hongyan Yan, Biyu Shen
Publikováno v:
Computational and Mathematical Methods in Medicine, Vol 2022 (2022)
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Objective. To systematically evaluate the effect of collaborative nursing on self-care ability of postcolostomy patients with colorectal cancer (CRC). Methods. PubMed, Web of Science, Embase, China National Knowledge Infrastructure, and Wanfang datab
Autor:
Xiaoli Li, yuyan Liu, Yuanyuan Xu, Jiaxiang Ding, Yue Su, Cuixia He, Minhui Zhu, Xiangdi Zhao, Ying Wang, Rongfang Shan, Yuanyuan Liu, Bingyan Liu, Jing Xie, Fei Guo, Yuzhou Ding, Huan Zhou, Zhiqiang Wang, Hongtao Li
SH-1028 is an irreversible third-generation EGFR tyrosine kinase inhibitor (EGFR-TKI) for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC). Considering the possibility of combination therapy in patients with NSCLC, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::793c048c23fdc7bd078b59efeddfec1f
https://doi.org/10.22541/au.166973114.48538191/v1
https://doi.org/10.22541/au.166973114.48538191/v1
Autor:
Ying Wang, Zhongbang Tang, Jing Xie, Xiaoqin Wang, Peng Ren, Guangmei Wu, Cuixia He, Minhui Zhu, Yue Su, Jiaxiang Ding, Yuanyuan Xu, Ling Fan, Qin Ge, Yuzhou Ding, Juan Zhu, Bingyan Liu, Rongfang Shan, Huan Zhou
Purpose Oseltamivir is mainly used for the treatment and prevention of influenza. The study was aimed at evaluating the bioequivalence and safety of oseltamivir phosphate suspension (Oselavir®), provided by Shenzhen Beimei Pharmaceutical Co.Ltd. and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76eacea9b8db7b1cca782cf5c3ea97bf
https://doi.org/10.21203/rs.3.rs-1958274/v1
https://doi.org/10.21203/rs.3.rs-1958274/v1
Publikováno v:
Contrast Media & Molecular Imaging.
The purpose of this study was to analyze the effect of early exercise rehabilitation on cardiopulmonary function and quality of life in patients after coronary artery bypass grafting (CABG). Eighty patients with coronary heart disease who underwent C